Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting

Bioconjugate Chemistry

Volumn 26, Issue 1, 2015, Pages 71-77

  Lin, Ran ^a   Zhang, Pengcheng ^a   Cheetham, Andrew G ^a   Walston, Jeremy ^b   Abadir, Peter ^b   Cui, Honggang ^a,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DICHROISM; MOLECULES; PEPTIDES;

'CURRENT; CELL-PENETRATING PEPTIDE; CELLULAR FUNCTION; CELLULAR UPTAKE; CONJUGATED MOLECULES; DIAGNOSTIC AGENTS; INTRACELLULAR ORGANELLE; MITOCHONDRIAS; SUBCELLULAR TARGETING; THERAPEUTIC AGENTS;

MITOCHONDRIA;

6 CARBOXYFLUORESCEIN; CELL PENETRATING PEPTIDE; 4-CARBOXYFLUORESCEIN; FLUORESCEIN DERIVATIVE;

ACID DISSOCIATION CONSTANT; ALPHA HELIX; ARTICLE; CELLULAR DISTRIBUTION; CIRCULAR DICHROISM; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HELA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERNALIZATION; MCF 7 CELL LINE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL TARGETING SIGNAL; MITOCHONDRION; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SOLID PHASE SYNTHESIS; AMINO ACID SEQUENCE; CHEMISTRY; CYTOSOL; MCF-7 CELL LINE; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; CELL-PENETRATING PEPTIDES; CYTOSOL; FLUORESCEINS; HELA CELLS; HUMANS; MCF-7 CELLS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT;

EID: 84921534709     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500408p     Document Type: Article

References (60)

1. Kroemer, G., Galluzzi, L., and Brenner, C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163.
2. Lin, M. T., and Beal, M. F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
3. Fulda, S., Galluzzi, L., and Kroemer, G. (2010) Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discovery 9, 447-464.
4. Abadir, P. M., Foster, D. B., Crow, M., Cooke, C. A., Rucker, J. J., Jain, A., Smith, B. J., Burks, T. N., Cohn, R. D., Fedarko, N. S., Carey, R. M., O'Rourke, B., and Walston, J. D. (2011) Identification and characterization of a functional mitochondrial angiotensin system. Proc. Natl. Acad. Sci. U.S.A. 108, 14849-14854.
5. Muratovska, A., Lightowlers, R. N., Taylor, R. W., Turnbull, D. M., Smith, R. A. J., Wilce, J. A., Martin, S. W., and Murphy, M. P. (2001) Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. 29, 1852-1863.
6. Mayer, A., Neupert, W., and Lill, R. (1995) Mitochondrial protein import - reversible binding of the presequence at the trans side of the outer-membrane drives partial translocation and unfolding. Cell 80, 127-137.
7. Schatz, G. (1996) The protein import system of mitochondria. J. Biol. Chem. 271, 31763-31766.
8. Schwarze, S. R., Hruska, K. A., and Dowdy, S. F. (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295.
9. Futaki, S. (2002) Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245, 1-7.
10. Weissig, V., D 'Souza, G. G. M., and Torchilin, V. P. (2001) DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J. Controlled Release 75, 401-408.
11. Yamada, Y., Akita, H., Kogure, K., Kamiya, H., and Harashima, H. (2007) Mitochondrial drug delivery and mitochondrial disease therapy - An approach to liposome-based delivery targeted to mitochondria. Mitochondrion 7, 63-71.
12. Jean, S. R., Tulumello, D. V., Wisnovsky, S. P., Lei, E. K., Pereira, M. P., and Kelley, S. O. (2014) Molecular vehicles for mitochondrial chemical biology and drug delivery. ACS Chem. Biol. 9, 323-333.
13. Kelley, S. O., Stewart, K. M., and Mourtada, R. (2011) Development of Novel Peptides for Mitochondrial Drug Delivery: Amino Acids Featuring Delocalized Lipophilic Cations. Pharm. Res. 28, 2808-2819.
14. Lei, E. K., Pereira, M. P., and Kelley, S. O. (2013) Tuning the intracellular bacterial targeting of peptidic vectors. Angew. Chem., Int. Ed. 52, 9660-9663.
15. Smith, R. A. J., Porteous, C. M., Coulter, C. V., and Murphy, M. P. (1999) Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem. 263, 709-716.
16. Chamberlain, G. R., Tulumello, D. V., and Kelley, S. O. (2013) Targeted delivery of doxorubicin to mitochondria. ACS Chem. Biol. 8, 1389-1395.
17. Flierl, A., Jackson, C., Cottrell, B., Murdock, D., Seibel, P., and Wallace, D. C. (2003) Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol. Ther. 7, 550-557.
18. Del Gaizo, V., MacKenzie, J. A., and Payne, R. M. (2003) Targeting proteins to mitochondria using Tat. Mol. Genet. Metab. 80, 170-180.
19. Patel, N. R., Hatziantoniou, S., Georgopoulos, A., Demetzos, C., Torchilin, V. P., Weissig, V., and D'Souza, G. G. M. (2010) Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol. J. Liposome Res. 20, 244-249.
20. Torchilin, V. P. (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 8, 343-375.
21. Yousif, L. F., Stewart, K. M., Horton, K. L., and Kelley, S. O. (2009) Mitochondria-penetrating peptides: sequence effects and model cargo transport. ChemBioChem 10, 2081-2088.
22. Vonheijne, G. (1986) Mitochondrial targeting sequences may form amphiphilic helices. EMBO J. 5, 1335-1342.
23. Karslake, C., Piotto, M. E., Pak, Y. K., Weiner, H., and Gorenstein, D. G. (1990) 2D NMR and structural model for a mitochondrial signal peptide bound to a micelle. Biochemistry 29, 9872-9878.
24. Pak, Y. K., and Weiner, H. (1990) Import of chemically synthesized signal peptides into rat-liver mitochondria. J. Biol. Chem. 265, 14298-14307.
25. Bode, S. A., Wallbrecher, R., Brock, R., van Hest, J. C. M., and Lowik, D. (2014) Activation of cell-penetrating peptides by disulfide bridge formation of truncated precursors. Chem. Commun. 50, 415-417.
26. Hansen, M. B., van Gaal, E., Minten, I., Storm, G., van Hest, J. C. M., and Lowik, D. (2012) Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. J. Controlled Release 164, 87-94.
27. Temming, R. P., Eggermont, L., van Eldijk, M. B., van Hest, J. C. M., and van Delft, F. L. (2013) N-terminal dual protein functionalization by strain-promoted alkyne-nitrone cycloaddition. Org. Biomol. Chem. 11, 2772-2779.
28. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
29. Zhang, P. C., Cheetham, A. G., Lin, Y. A., and Cui, H. (2013) Self-assembled Tat nanofibers as effective drug carrier and transporter. ACS Nano 7, 5965-5977.
30. Zhang, P. C., Cheetham, A. G., Lock, L. L., and Cui, H. G. (2013) Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site. Bioconjugate Chem. 24, 604-613.
31. Zhang, P. C., Lock, L. L., Cheetham, A. G., and Cui, H. G. (2014) Enhanced cellular entry and efficacy of Tat conjugates by rational design of the auxiliary segment. Mol. Pharmaceutics 11, 964-973.
32. Zhang, K., Fang, H. F., Chen, Z. Y., Taylor, J. S. A., and Wooley, K. L. (2008) Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. Bioconjugate Chem. 19, 1880-1887.
33. Derossi, D., Chassaing, G., and Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8, 84-87.
34. Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G., and Rothbard, J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325.
35. Lindgren, M., Hallbrink, M., Prochiantz, A., and Langel, U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
36. Copolovici, D. M., Langel, K., Eriste, E., and Langel, U. (2014) Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 8, 1972-1994.
37. Ryser, H. J., and Hancock, R. (1965) Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150, 501-3.
38. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315.
39. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55, 1179-1188.
40. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
41. Futaki, S., Nakase, I., Suzuki, T., Youjun, Z., and Sugiura, Y. (2002) Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41, 7925-7930.
42. Wang, Y., and Weiner, H. (1993) The presequence of rat-liver aldehyde dehydrogenase requires the presence of an alpha-helix at its N-terminal region which is stabilized by the helix at its C-termini. J. Biol. Chem. 268, 4759-4765.
43. Takayama, K., Nakase, I., Michiue, H., Takeuchi, T., Tomizawa, K., Matsui, H., and Futaki, S. (2009) Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas). J. Controlled Release 138, 128-133.
44. Varkouhi, A. K., Scholte, M., Storm, G., and Haisma, H. J. (2011) Endosomal escape pathways for delivery of biologicals. J. Controlled Release 151, 220-228.
45. Murphy, R. F., Powers, S., and Cantor, C. R. (1984) Endosome pH measured in single cells by dual fluorescence flow-cytometry - rapid acidification of insulin to pH-6. J. Cell Biol. 98, 1757-1762.
46. Fernandez-Suarez, M., and Ting, A. Y. (2008) Fluorescent probes for super-resolution imaging in living cells. Nat. Rev. Mol. Cell Biol. 9, 929-943.
47. Bailey, C. A., Miller, D. K., and Lenard, J. (1984) Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells. Virology 133, 111-118.
48. Jiang, T. Y., Zhang, Z. H., Zhang, Y. L., Lv, H. X., Zhou, J. P., Li, C. C., Hou, L. L., and Zhang, Q. (2012) Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33, 9246-9258.
49. Appelbaum, J. S., LaRochelle, J. R., Smith, B. A., Balkin, D. M., Holub, J. M., and Schepartz, A. (2012) Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm. Chem. Biol. 19, 819-830.
50. Lindberg, M., Jarvet, J., Langel, U., and Graslund, A. (2001) Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochemistry 40, 3141-3149.
51. Magzoub, M., Kilk, K., Eriksson, L. E. G., Langel, U., and Graslund, A. (2001) Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim. Biophys. Acta, Biomembr. 1512 , 77-89.
52. Magzoub, M., Eriksson, L. E. G., and Graslund, A. (2002) Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration. Biochim. Biophys. Acta, Biomembr. 1563, 53-63.
53. Eiriksdottir, E., Konate, K., Langel, U., Divita, G., and Deshayes, S. (2010) Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim. Biophys. Acta, Biomembr. 1798, 1119-1128.
54. Park, C. B., Yi, K. S., Matsuzaki, K., Kim, M. S., and Kim, S. C. (2000) Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 97, 8245-8250.
55. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866.
56. Neupert, W., and Herrmann, J. M. (2007) Translocation of proteins into mitochondria. Annu. Rev. Biochem. 76, 723-749.
57. Marrache, S., and Dhar, S. (2012) Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc. Natl. Acad. Sci. U.S.A. 109, 16288-16293.
58. Boddapati, S. V., D'Souza, G. G. M., Erdogan, S., Torchilin, V. P., and Weissig, V. (2008) Organelle-targeted nanocarriers: Specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett. 8, 2559-2563.
59. Dabir, D. V., Hasson, S. A., Setoguchi, K., Johnson, M. E., Wongkongkathep, P., Douglas, C. J., Zimmerman, J., Damoiseaux, R., Teitell, M. A., and Koehler, C. M. (2013) A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev. Cell 25, 81-92.
60. Lovric, J., Bazzi, H. S., Cuie, Y., Fortin, G. R. A., Winnik, F. M., and Maysinger, D. (2005) Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 83, 377-385.